Clinical Trials Logo

Clinical Trial Summary

Facial scans of newborns will be performed before and after implementation of respiratory support devices such as nasal CPAP. 3D scanned images will be processed by Fisher & Paykel Healthcare Limited. Images will be analyzed for changes or distortion in nasal structure.


Clinical Trial Description

Any newborns admitted to the neonatal intensive care unit at Sharp Mary Birch Hospital for Women and Newborns between 24-42 weeks CGA with parental informed consent are eligible. 3D scanned image will be obtained prior to implementation of nasal support devices and after nasal support devices. Fisher & Paykel Healthcare Limited will analyze the 3D images and observations will be made for changes in nasal structure or distortion. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02603796
Study type Observational
Source Sharp HealthCare
Contact
Status Completed
Phase N/A
Start date October 2015
Completion date June 2016

See also
  Status Clinical Trial Phase
Terminated NCT02815345 - Objectives and Measures Dimensions Nasal Resistance of Preterm and Term (MODERN) N/A
Suspended NCT03624608 - Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures N/A
Withdrawn NCT04334590 - Fabrication of Sequential Naso-Alveolar Molding Appliances in the Treatment of Cleft Lip/Nose Deformities
Completed NCT01827020 - Effect of Ketamine Addition to Lidocaine in Rhinoplasty Phase 4
Completed NCT00467714 - Evaluation Of Cloumella Strut Effect In Tip Rotation Phase 4
Completed NCT00545428 - Mastoid Bone Autograft for Dorsal Nasal Augmentation N/A